ABSTRACT
INTRODUCTION
The popularity of plant-based drug in the modern system of medicine is growing day by day as they are claimed to be safe, economical and yet efficacious (1) (2) (3) . The adverse drug reaction of synthetic medicines in the treatment of diabetes mellitus has restricted in a growing demand for the use of herbal drug or Phytomedicines (4) . However, there is still an unmet need for improved oral drugs from medicinal plants for Diabetes Mellitus.
The Cynodon dactylon (Family: Poaceae) commonly known as "Doob; Hindi" "Aroogum pillo; Tamil", "Garike; Telulgu" and "Bermuda grass; English" in India is a creeper. It is a weed and has been regarded to possess varied medicinal properties (5) . The aqueous fluid extract of the rhizome is used as antiinflammatory, diuretic, antiemetic, antidiabetic and blood purifying agent (6) . Since, high potential of hypoglycemic, hypolipidemic and antioxidant activities of both aqueous and ethanolic extracts have already been reported by our research group (7-9) therefore, the present study was taken into consideration for evaluating the hepatoprotective effect of ethanolic extract of Cynodon dactylon on STZ induced hepatic injury in severely diabetic animal models. This extract can be treated as new addition to therapeutic armamentarium of drugs to combat the rapidly increasing number of diabetic patients in this country especially when the existing drugs are becoming very expensive.
MATERIALS AND METHODS

Reagents:
Streptozotocin was purchased from Sigma-Aldrich Co. USA. Commercial kits were purchased from Bayer Diagnostics, India Ltd for enzymatic assays. One touch (Accuchek sensor) of Roche, Germany for BGL and glucose based Uristix, from Bayer Diagnostics India Ltd for urine sugar were used.
Extract : Cynodon dactylon was collected from the campus of University of Allahabad, Allahabad, India in the month of August. It was identified and authenticated by Botanical Survey Animals: More than fifty albino Wistar rats of body weight 180-220 g selected for the experiment were kept in standard conditions of temperature (23±5°C) and relative humidity (55±5%) with a 12h each of dark and light cycle. Animals were fed with commercial pellet diet (Golden feed, New Delhi) and water ad-libitum.
Diabetes was induced to a group of 14 overnight fasted rats by a single intraperitonial injection of freshly prepared solution of streptozotocin (55 mg/kg body weight) in 0.1M citrate buffer (pH= 4.5). After one week of STZ administration animals with marked hyperglycemia (FBG>250 mg/dl) were selected for the study considering severely diabetic.
Experimental Design: Pre identified most effective dose of 500 mg/kg of Cynodon dactylon (7-8) ethanolic extract was selected for the study. All biochemical parameters were estimated in blood serum. Four groups of six rats each were designed: Group I-Normal control (received vehicle); Group II-Normal treated (received 500 mg/kg body weight extract); Group III-Diabetic control (received vehicle); Group IV-Diabetic treated (received 500 mg/kg body weight extract)
Group I and III served as normal and diabetic control received vehicle (distilled water) only, whereas, groups II and IV were treated once daily for 14 days with the dose of 500 mg/kg body weight of ethanolic extract Cynodon dactylon. Various biochemical parameters like BGL, Hb, US, ALP, CREA, SGOT, SGPT and TP along with body weight were taken initially and then weekly up to 2 weeks.
Biochemical parameters: Blood glucose (10), Alkaline phosphatase (ALP) (11), glutamate oxaloacetate transaminase (SGOT), glutamate pyruvate transaminase (SGPT) (12), creatinine (CREA) (13), total protein (TP) (14) and haemoglobin (Hb) (15) were estimated. All the kits used were purchased from Bayer Diagnostic, India, Ltd. Urine sugar was detected by uristix. All the parameters were measured initially before the treatment and then monitored every week upto 2 weeks inclusive of body weight.
LD 50 Experiment: Four groups having six normal healthy rats
Curative Effect of Cynodon dactylon Statistical analysis: Data were statistically evaluated using one-way ANOVA, followed by a post hoc Scheffe's test using the SPSS computer software, version 7.5. The values were considered significant when P<0.05. Table 1 indicates the significant decline of 30.28 and 14.75% in the raised levels of SGOT and SGPT respectively of severely diabetic rats on 14 days treatment indicating thereby its hepatoprotective effect. This effect was further confirmed by a fall of 33.05% in ALP levels of severely diabetic rats shown in Table 2 .
RESULTS
Liver Function Tests (SGOT, SGPT and ALP):
Creatinine (CREA): Increased creatinine levels of severely diabetic animals was an indication of diabetes induced mal functioning of kidney. However, Table 2 shows the sharp decrease of 41.61% in its level of diabetic animals as compared to initial values as an additional advantage of treatment with ethanolic extracts of Cynodon dactylon.
Total haemoglobin and total protein (Hb and TP):
Moreover, Table 3 observes that the decrease in haemoglobin and total protein levels of diabetic rats was also raised by 15.54 and 15.73% on extract treatment for 14 days. Table  4 clearly shows the decrease of 75% in urine sugar level as it comes down from +4 to +1 in case of treated severely diabetic rats. Moreover, the result given in Table 4 also reveals that the body weight (body weight) in case of treated diabetic groups with ethanolic extract for 14 days increased by 17.4 g.
Urine sugar and body weight (US and body weight):
LD 50 :
No toxic effect was reported at doses upto 15 and 20 times the effective dose as the behavior of experimental animals was normal and no mortality was observed in any of these groups.
DISCUSSION
Cynodon dactylon is traditionally used in India as a therapeutic agent to control diabetes mellitus. Our earlier reports on aqueous and ethanolic extracts of Cynodon dactylon (8, 9) also reveal its antidiabetic effect in severely diabetic models on 2 weeks treatment. Lowering of high lipid profile of diabetic rats with increase in cardioprotective lipid (HDL) was an additional observation of these reports. The present scientific investigation not only supports but validates too the traditional use of Cynodon dactylon as antidiabetic agent of high potential in diabetic models.
The elevated level of SGOT, SGPT and ALP in severely diabetic experimental rats was observed after one week of STZ administration as an indication of STZ induced hepatic injury (16) . The data suggested that the 14 days long administration of ethanolic extract of Cynodon dactylon improves the liver function by decreasing the raised levels of SGOT, SGPT and ALP of severely diabetic rats. Hence, the present study reconfirms our previous observations about antidiabetic effect by showing improvement in enzymatic assays affected due to hepatic injury caused by STZ induced diabetes. The serum creatinine level of severely treated diabetic rats was also found to decrease on treatment suggesting theirby an improvement in kidney function also in addition to liver function (17) .
Levels of total haemoglobin, total protein and urine sugar and body weight were additional parameters taken into consideration for validating the effect of extract treatment by finding improvement in all of them. Since, high LD 50 indicates high margin of safety therefore the extract can be effectively used to control diabetes mellitus and its related complications.
